Study at a glance
Why do vitamin D and iron studies reach different results?
They study people with different iron stores, vitamin D levels, inflammation and kidney function. They also measure different outcomes. A change in an iron-regulating hormone is not the same as correcting anaemia.
What does hepcidin have to do with vitamin D?
Hepcidin is a hormone that limits how much iron becomes available in the blood. Vitamin D can lower it in some studies, but that does not guarantee more usable iron or better red-cell production.
Can a fall in ferritin mean something other than lost iron?
Yes. Ferritin is a blood marker related to iron stores, but it can also rise with inflammation. When inflammation improves, ferritin may fall without proving that iron stores have worsened.
Read the full article below ↓Vitamin D and iron research can appear contradictory because studies are often testing different physiological states. In one experiment, vitamin D can rapidly reduce hepcidin. In another population, months of supplementation can leave ferritin, transferrin saturation and haemoglobin essentially unchanged. Both findings can be valid. The apparent contradiction disappears once the pathway is separated into vitamin D signalling, hepcidin regulation, iron mobilisation, actual iron stores, inflammation, kidney function and erythropoiesis. These layers are part of Vitamin D and Iron Metabolism, but no single layer predicts the whole outcome.
A molecular mechanism is not automatically a clinical treatment effect
Vitamin D can suppress HAMP transcription and reduce circulating hepcidin under some conditions. That is a real mechanism. But haemoglobin will increase only if iron availability is an important limiting factor and if the rest of the erythropoietic system can use the additional iron.
A person with adequate iron availability may show little benefit from further hepcidin reduction. A person with blood loss may need replacement of depleted iron. A person with renal anaemia may have inadequate erythropoietin. A person with active inflammation may have several iron-regulatory and marrow-suppressive signals operating simultaneously.
Baseline state changes the meaning of the intervention
Vitamin D supplementation is most likely to reveal a vitamin-D-dependent effect when vitamin D signalling is actually constraining the pathway. If participants begin with relatively adequate status, raising 25(OH)D further may not meaningfully alter iron physiology.
This is one reason subgroup results sometimes differ between people with lower and higher baseline 25(OH)D. It does not prove a universal threshold. It shows that physiological starting conditions can change response, consistent with Vitamin D Response.
Inflammation changes both hepcidin and the interpretation of ferritin
Inflammation can increase hepcidin and ferritin at the same time. Hepcidin reduces iron export, while ferritin can rise as an acute-phase protein. A patient can therefore have restricted usable iron despite a ferritin concentration that would look reassuring outside inflammatory disease.
When inflammation improves, both hepcidin and ferritin can fall. That pattern is not necessarily evidence that iron stores have worsened. The surrounding inflammatory physiology described in Vitamin D and Inflammatory Signalling determines what the laboratory changes mean.
Kidney disease changes several parts of the pathway simultaneously
Chronic kidney disease can alter hepcidin clearance, active vitamin D metabolism, inflammation and erythropoietin production. Dialysis, iron therapy and erythropoiesis-stimulating agents add further variables. Results from CKD populations therefore should not be expected to reproduce healthy-adult hepcidin experiments exactly.
This is why the kidney context should remain visible rather than treating CKD as merely another low-vitamin-D population. Vitamin D and Kidneys develops those renal differences in more detail.
25(OH)D and active vitamin D are not interchangeable
Most clinical studies classify vitamin D status using 25(OH)D. The transcriptional regulation of hepcidin is mediated by active vitamin D signalling through VDR. Local conversion and renal endocrine production therefore matter. A high or low 25(OH)D concentration does not provide a complete measurement of local VDR activity.
This distinction is explained in Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D.
Different outcomes answer different questions
Hepcidin asks whether the iron-regulatory signal changed. Transferrin saturation asks how much transport capacity is occupied by iron. Ferritin provides information about storage but is inflammation-sensitive. Haemoglobin asks whether erythropoiesis eventually produced more circulating red-cell mass.
Those outcomes sit at different positions in the causal chain. A treatment can affect one without affecting all the others. The mistake is not that studies measure different endpoints; it is treating those endpoints as though they were interchangeable.
The useful conclusion is conditional rather than contradictory
Vitamin D can regulate the hepcidin-ferroportin system. Inflammation can amplify iron restriction. Some deficient or disease-specific populations may show improved iron availability or erythropoietic outcomes after vitamin D supplementation. Other populations show no clinically meaningful change.
The evidence therefore supports a conditional physiological relationship rather than a universal supplementation claim. That is why seemingly contradictory vitamin D and iron studies can coexist without the underlying science being incoherent.
Related reading
Prevalence and Predictors of Self-Prescribed Vitamin D Supplementation Among University Students in the UAE
Among participants, 44.9% reported self-prescribed vitamin D use.
Original paper ↗Read more →Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation
Markers of the renal-bone axis, inflammation and iron status were investigated pre: and post-supplementation.
Original paper ↗Read more →Intact FGF23 and Markers of Iron Homeostasis, Inflammation, and Bone Mineral Metabolism in Acute Pediatric Infections
The aim of this prospective clinical study is to evaluate the association of i-FGF23 with hepcidin and markers of iron homeostasis, erythropoiesis, inflammation, and bone mineral metabolism in acute pediatric infections.
Original paper ↗Read more →Multiple Indicators of Undernutrition, Infection, and Inflammation in Lactating Women Are Associated with Maternal Iron Status and Infant Anthropometry in Panama: The MINDI Cohort
Maternal infections, nutrient deficiencies, and inflammation (MINDI) co-exist in lactating indigenous women in Panama, but their impact on maternal iron status and infant growth is unknown.
Original paper ↗Read more →Multiple Infections, Nutrient Deficiencies, and Inflammation as Determinants of Anemia and Iron Status during Pregnancy: The MINDI Cohort
In pregnant women with multiple infections, nutrient deficiencies, and inflammation (MINDI), the study of anemia and iron status is limited.
Original paper ↗Read more →The Effect of Vitamin D Supplementation on Hepcidin, Iron Status, and Inflammation in Pregnant Women in the United Kingdom
Our aim was to identify whether antenatal vitamin D3 supplementation affects iron status (via hepcidin suppression) and/or inflammation.
Original paper ↗Read more →Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Full Study
Evidence linking vitamin D status with inflammation, hepcidin, iron restriction and haemoglobin in inflammatory disease.
Read more →Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Study Summary
A concise review of vitamin D, inflammatory hepcidin signalling, iron restriction and anaemia-related physiology.
Read more →Assessment of Vitamin D status and association with inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project
We examined correlations between inflammation biomarkers, CRP or alpha-1-acid glycoprotein (AGP), and serum 25(OH)D concentrations among preschool children (PSC; 6 to 59 mo) and nonpregnant females of reproductive age (FRA; 15 to 49 y).
Original paper ↗Read more →Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease
In this large-scale prospective cohort study, we investigated this relationship and examined whether high FGF23 levels increase the risk of incident anemia.
Original paper ↗Read more →Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease
Anemia is a common and disabling complication of chronic kidney disease (CKD).
Original paper ↗Read more →An Inflammation-Adjusted Framework for Nutritional Assessment in Multimorbid Patients with Advanced Neurological Diseases
Background and Objectives: Laboratory parameters associated with nutritional and metabolic status may be substantially influenced by inflammatory activity, complicating their interpretation in patients with advanced neurological diseases.
Original paper ↗Read more →Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease
Our primary objective was to determine the association between ssEFV and coronary artery calcification (CAC).
Original paper ↗Read more →Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
Therefore, we conducted a study to determine whether paricalcitol, compared to calcitriol, improves anemia in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Factors Contributing to Negative Outcomes Associated with Medications and Drug-Related Problems in Kidney Replacement Therapy: A Hospital-Based Prospective Observational Study
Background: Negative outcomes associated with medications (NOM) and drug-related problems (DRP) significantly impact individuals with kidney replacement therapy (KRT) given the complexities of managing kidney disease and associated comorbidities.
Original paper ↗Read more →Leveraging practice-based research networks to accelerate implementation and diffusion of chronic kidney disease guidelines in primary care practices: a prospective cohort study
Motivated practices from four PBRNs received baseline and periodic performance feedback, academic detailing, and weekly practice facilitation for 6 months during wave I of the study.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →The combination of vitamin D3 and erythropoietin alleviates acute kidney injury induced by ischemia-reperfusion via inhibiting inflammation and apoptosis
Acute renal ischemia may cause acute renal dysfunction due to lack of blood supply; the manifestations are renal tubular cell apoptosis, infiltration of macrophages, and microvascular destruction.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography
The purpose of our study was to explore the potential role of urinary VDBP as a biomarker of an acute renal damage.
Original paper ↗Read more →Vitamin D as a modulator of pain and inflammation in postmenopausal females with burning mouth syndrome
The aim of this study was to investigate relationship between vitamin D levels and clinical features in postmenopausal females with burning mouth syndrome (BMS).
Original paper ↗Read more →